Healthcare - Biotechnology - NASDAQ - US
$ 26.49
-3.67 %
$ 2.48 B
Market Cap
-11.93
P/E
Price Target
Average
30.24%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--15.59%
Net Income
Estimate
25.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Scholar Rock Holding Corporation
Wall Street analysts predict an average 1-year price target for SRRK of $34.5 , with forecasts ranging from a low of $28 to a high of $42 .
SRRK Lowest Price Target
Wall Street Target
28 USD
5.70%
SRRK Average Price Target
Wall Street Target
34.5 USD
30.24%
SRRK Highest Price Target
Wall Street Target
42 USD
58.55%
REVENUE FORECAST
Revenue Forecast Chart SRRK
EBIT FORECAST
EBIT Forecast Chart SRRK
NET INCOME FORECAST
Net Income Chart SRRK